Pharvaris N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Pharvaris N.V. on September 8, 2025, covering the month of September 2025. The filing reports on a corporate governance event rather than periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual agreement regarding equity securities.
Material Changes and Events
- Registration Rights Agreement: On September 2, 2025, the Company entered into a Registration Rights Agreement with General Atlantic PH B.V.
- Underlying Securities: The agreement covers up to 500,000 ordinary shares (par value €0.12) resulting from the exercise of pre-funded warrants.
- Origin of Warrants: The pre-funded warrants were acquired by the Investor in an underwritten offering that closed on July 24, 2025.
- Terms: The agreement includes customary demand registration rights and indemnification provisions.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors beyond the standard incorporation of the agreement text. The document serves to disclose the execution of the Registration Rights Agreement and incorporates the full text as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the full terms of the Registration Rights Agreement in Exhibit 99.1.
- Confirm the status of the 500,000 ordinary shares issued upon the exercise of pre-funded warrants.
- Review the Company's Form F-3 and Form S-8 registration statements where this report is incorporated by reference.
- Note that no financial performance data is included in this specific filing.